In hepatocellular carcinoma cells, resistance to the EGFR inhibitor gefitinib and cell stemness markers were found associated with increased IGF-IR nuclear translocation (29), a phenomenon recently described to occur in cancer cells (30). Here, IGF1R is linked to cancer.